Biography & Education

Personal Statement: I continue to be enthused by our congenial hybrid of a formal academic medical center and a functional community hospital here in Portland. I strive to provide optimal patient care, teaching and community service.Areas of Academic Focus:Antimicrobial pharmacodynamicsHIVNational/Regional Responsibilities:Regional Chairman, Pharmacy & Therapeutics Committee, Providence HeaLth & ServicesMember, PPMC Clinical Decision Support CommitteeNorthwest AIDS Education and Training Center preceptorPast president, Infectious Diseases Society of OregonAd hoc member, Anti-Infective Drugs Advisory Committee, Food and Drug Administration (FDA)Member, Editorial Board, Antimicrobial Agents ChemotherapyChairperson, PPMC Clinical Decision Support CommitteeSignificant Publications:Gilbert, Leggett: Chapter on Aminoglycosides. Mandell, Doyles and Bennett. Principles and Practice of Infectious Diseases. Elsevier; Philadelphia, 2009-10Leggett J. Approach to Fever and Suspected Infection in the Normal Host. Chapter 302. Cecil's Medicine, 23rd Edition, Saunders, 2008; pp 2112-2118.Saravolatz LD, Leggett J. Gatifloxacin, gemifloxacin, and moxifloxacin: the role for three new fluoroquinolones. Clin Infect Dis 2003; 37:1210-1215.Gilbert DN et al. A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate. Am J Med 1998;105:182-91.Bermada S et al. Correlation of tobramycin-induced inhibition of protein synthesis with postantibiotic effect in E. coli. Antimicrob Agents Chemother 1993;37:2678-2683.Leggett JE et al. Comparative antibiotic dose-effect relationships at several dosing intervals in murine pneumonitis and thigh infection models. J Infect Dis 1989;159:281-92.Vogelman B et al. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis 1988;158:831-47.Vogelman B et al. The in vivo postantibiotic effect in a thigh infection in neutropenic mice. J Infect Dis 1988;157:287-98.Presentations:MRSA: An Evolving PathogenBad Bugs, No Drugs: Big PhRMA and the FDA.Limitations of animal models.Pharmacokinetics/pharmacodynamics.Teaching Responsibilities:Attending for the Infectious Diseases Service 12 months a year.Preceptor for internal medicine residents in weekly HIV clinics.
Areas of expertise

Infectious Disease


Medical degree: University of Kentucky, Lexington
Residency: University of Wisconsin, Madison - Internal Medicine
Fellowship: University of Wisconsin, Madison - Infectious Diseases

  • English
  • French
  • Italian
  • Spanish

Care Locations

5050 NE Hoyt St.
Suite 540
Portland, OR 97213
Fax 503-215-6727


Board Certifications
  • Infectious disease
  • Internal medicine


Patient Ratings and Comments
About Our Survey

The Patient Rating score is based on responses given during the CAHPS Patient Experience Survey. Responses are measured on a 10-point scale, with 10 being the best score. These scores are then translated to a 5-point scale in order to display results in a 5-star rating. Comments are also gathered from the same survey and displayed in their entirety with the exception of any language that may be considered slander, libel or contain private health information, which will be removed prior to publishing the comments. These comments are the views and opinions of patients and are not endorsed by or necessarily reflect the views of Providence.

4.8 out of 5 (36 Ratings, 7 Comments)


Dr. Legget is very straight. Tells you what he thinks about the condition and whether or not you should do it is up to me. He explains in my understanding and very kind.

All good he is the best.

Dr Leggett is the best

[...] is developmentally disabled and Dr. Legitt is so respectful and patient with her. He always talks with her about her health and listens. makes her feel heard and acknowledged.

It is always a very good experience when I go see Dr.Leggett. He is alway kind and very helpful.

I have had very good care from this provider

All way glad to see them.